3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
8
Breast Neoplasms
8
Neoplasms
7
Depression
6
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lymphoma, Mantle-Cell
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Head and Neck Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Anxiety Disorders
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Prostatic Hyperplasia
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell, Marginal Zone
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Kidney Neoplasms
2
Fatigue
2
Interventions
Etoposide
7
Cisplatin
7
fludarabine
4
Cyclophosphamide
4
fludarabine phosphate
3
Paclitaxel
3
Carboplatin
3
Bleomycin
3
Automobiles
3
pembrolizumab
2
etoposide phosphate
2
Vorinostat
2
Sirolimus
2
Mesna
2
Ifosfamide
2
Drug Therapy
2
130-nm albumin-bound paclitaxel
2
tremelimumab
1
sodium thiosulfate
1
repotrectinib
1
pralsetinib
1
pegfilgrastim
1
lutetium Lu 177 dotatate
1
durvalumab
1
cabozantinib
1
Watchful Waiting
1
Teniposide
1
Surveys and Questionnaires
1
Stem Cell Transplantation
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Therapeutics
×
1 year
×
Clear all
No trials found.